We’re thrilled to announce that Dr. Robert Califf will be our keynote FDA speaker, joining us in-person for a special “Fireside Chat.” Don’t miss this opportunity to hear from top industry professionals and thought leaders!

GRx+Biosims 2023 is the premier scientific & regulatory and policy event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees' understanding of how to succeed in generic and biosimilar development, regulatory process and approvals, and the evolving policy landscape.

Entrepreneur and founder of the Mark Cuban Cost Plus Drug Company, PBC, Mark Cuban, sat down with our new Board Chair Christine Baeder, SVP, COO for US Generics at Teva Pharmaceuticals, to discuss his efforts to reduce #drugprices and increase competition in the drug market.

Follow updates on social media with hashtag #Access2023.